One
of the Landmark Group’s key projects is the development and management
of public hospitals in China. The large Chinese public healthcare sector
(a population of 1.4 billion, and 16,781 mid-to-large public
hospitals), along with the government’s favorable view of improving the
quality of public hospitals through investment has made Landmark a key
player in the field.
Landmark’s
development of public hospitals in China includes modernization of
healthcare standards, technologies and equipment, as well as the
introduction of modern management techniques, reconstruction of hospital
teams and personnel, networking of strategically-located hospitals and
collaboration with international medical institutes. These steps not
only improved the service given to patients, but also increased the
revenue generated by the hospitals.
Among
Landmark’s notable healthcare projects is the Xinan Binggong Hospital
in Sichuan. As a result of Landmark’s investment and management, the
hospital has not only increased its revenue, but also managed to show
steadily-growing profit for the first time.
One
of Landmark’s greatest advantaged in the Chinese public healthcare
sector is its status as early mover, as it was one of the first
companies to recognize the sector’s potential. The group also takes
pride in its excellent relationship with Chinese institutes, and the
respect for its people’s expertise in China (Landmark’s chairman, Doron
Biran has lectured as part-time professor at Beijing’s Tsinghua
University). The group has obtained a valuable, and difficult to obtain,
private sector license for hospital management. It has set a very high
bar for any company that want to enter the Chinese public healthcare sector in the future.
Click here to see our SinoCare Healthcare presentation.